ckd and semaglutide VisualAbstract: Improves Outcomes in Patients with Type 2 Diabetes Chronic Kidney Disease Semaglutide could be 'practice changing'

The approach the article describes instead is a gradual reduction with the new medication started alongside it, under medical supervision, which it says typically reduces that risk and allows symptoms to be monitored through the transition rather than after the fact

Addressing this dual role is essential for designing effective therapeutic interventions

Millennials were the most inclined to view GLP-1s as a "shortcut" weight loss method (77%) while Gen X was the most likely to reject this idea (33%)

Our clinic may recommend nutrition guidance, lifestyle coaching, body composition tracking, and medication support when appropriate